Support WBURFDA Decision Signals New Competition For Some Of The Costliest DrugsPlay03:43Download AudioElana GordonMarch 10, 2015 ShareA look inside the factory in Kundl, Austria, where Sandoz, a unit of Novartis, makes biosimilar drugs. (Novartis)